HSN-2A

WNK1 | 2008

What Is HSN-2A?

HSN-2A is a type of CMT caused by autosomal recessive mutations in the WNK1 gene. This gene provides instructions for making a protein kinase that helps regulate ion balance and signaling in the sensory nervous system. Mutations in the WNK1 gene disrupt this function, leading to impaired nerve signal transmission.

HSN-2A is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in HSN-2A is variable, ranging from childhood to adulthood. The disease involves loss of sensation that begins in the hands and feet (glove-and-stocking distribution) and progresses over time towards the center of the body. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

HSN-2A symptoms may include:

  • Progressive loss of sensation in the feet and hands
  • Loss of pain and temperature sensation
  • Reduced or absent reflexes
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Distal weakness that develops as the disease progresses
  • Foot drop
  • Additional symptoms not listed here

Disease Course

HSN-2A shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
HSN-2A

Classification
HSN

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
WNK1

Gene Full Name
WNK lysine deficient protein kinase 1

Chromosome
12p13.33

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Variant Mechanism

Loss of Function (LoF)

Details

Mechanistic basis:
Complete loss

Confidence:
High

Prediction:
Nonsense-mediated decay is the operative lesion in HSN-2A, and the literature predicts biallelic loss of function: premature stop codons in the HSN2 exon send the neuron-specific WNK1 transcript to degradation, and alleles that escape decay yield a truncated product stripped of the kinase context it serves. Disease requires both copies of the neuronal isoform to be inactivated, and returning that isoform is predicted to restore function in sensory neurons.

Rationale:
Transcript degradation, not a toxic peptide, is what the HSN2 stop codons produce, so the neuronal WNK1 pathway is simply absent in homozygotes and compound heterozygotes while single-allele carriers retain normal sensation. Restriction of HSN2 expression to the nervous system confines that absence to sensory and autonomic neurons.

ClinVar Pathogenic Variants

View WNK1 ClinVar Variants

HSN-2A OMIM Entry

HSN-2A OMIM

WNK1 OMIM Entry

WNK1 OMIM

More Info

HSN-2A Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Mutations in the nervous system–specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II

Authors

Shekarabi, M., Girard, N., Rivière, J. B., Dion, P., Houle, M., Toulouse, A., Lafrenière, R. G.

Publication Date
June 2, 2008

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


A Name That Does Too Much Work

Jean-Martin Charcot's name appears throughout medicine, but nowhere does it create more confusion than in the foot. Learn why the CMT foot and Charcot neuroarthropathy, also known as Charcot foot, share a name yet differ in how they develop, appear, and are managed.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.